MARSTACIMAB

UNII:	0UB3OA67O7
Formula:
Preferred Substance Name:	MARSTACIMAB

1985638-39-8
HYMPAVZI
IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR (TFPI, EXTRINSIC PATHWAY INHIBITOR, EPI, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, LACI))
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR (TFPI, EXTRINSIC PATHWAY INHIBITOR, EPI, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, LACI)) HUMAN MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-449) (HUMAN VH (HOMO SAPIENS IGHV-23*01(IGHD)-IGHJ3*02) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*03 (CH1 R97>K(217), CH2 L4>A(237),L5>A(238),G7>A(240), CH3 K107>-(DEL)) (121-449)) (223-217')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'-218') (HUMAN V-LAMBDA (HOMO SAPIENS IGLV1-40*01-IGLJ2*01) (9.3.12) (1'-112')-HOMO SAPIENS IGLC2*01 (113'-218')) DIMER (229-229'':232-232'')-BISDISULFIDE
MARSTACIMAB [INN]
MARSTACIMAB [USAN]
MARSTACIMAB-HNCQ
PF-06741086

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MARSTACIMAB

Synonyms and Mappings

Resources